SCHEMBL4750668

SCHEMBL4750668

c1ccc(-c2cccc(-c3ccc(N(c4ccccc4)c4ccc(-c5nc6ccccc6nc5-c5ccc(N(c6ccccc6)c6ccc(-c7cccc(-c8ccccc8)c7)cc6)cc5)cc4)cc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.51
L3MBTL1 Q9Y468 5/20 0.51
LMNA P02545 4/20 0.51
GAA P10253 3/20 0.51
TDP1 Q9NUW8 2/20 0.51
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 7/20 0.47
NPSR1 Q6W5P4 1/20 0.47
THRB P10828 1/20 0.46
AKT1 P31749 1/20 0.45
AKT2 P31751 1/20 0.45
PDE10A Q9Y233 1/20 0.45
ATM Q13315 1/20 0.45
TLR9 Q9NR96 1/20 0.45
PKM P14618 1/20 0.44
PIK3R1 P27986 1/20 0.42
PIK3CA P42336 1/20 0.42
HPGD P15428 3/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724267 1.00 KDM4E (0.51) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL12690714 1.00 KDM4E (0.51) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL6725000 0.98 KDM4E (0.50) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL12146773 0.98 KDM4E (0.50) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL12146593 0.98 KDM4E (0.50) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL12207320 0.98 KDM4E (0.50) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL12146770 0.98 KDM4E (0.50) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL6724360 0.98 KDM4E (0.53) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL6724511 0.98 KDM4E (0.53) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL6724418 0.98 KDM4E (0.53) KDM4EL3MBTL1LMNAGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623523-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-01-07 US disclosed
US-8623523-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-01-07 US disclosed
US-20120211738-A1 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
US-20120211738-A1 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
US-8173277-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-08 US disclosed
US-8173277-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-08 US disclosed
US-20110186825-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-08-04 US disclosed
US-20110186825-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2011-08-04 US disclosed
US-7901792-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-08 US disclosed
US-7901792-B2 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-08 US disclosed
WO-2007032258-A1 QUINOXALINE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE USING THE SAME SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-03-22 WO disclosed
US-20070059553-A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-03-15 US disclosed
US-20070059553-A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070059553-A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same CRY1, CRY2, ARL1 KDM4E 347/4885L3MBTL1 1258/4885LMNA 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.